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Abstract
Recent work on the use of mRNA lipoplexes for gene delivery demonstrates the need for a mathematical model that
simulates and predicts kinetics and transfection efficiency. The small copy numbers involved make it necessary to use
stochastic models and include statistical analysis of the variation observed in the experimental data. The modeling
requirements are further complicated by the multi-level nature of the problem, where mRNA molecules are contained in
lipoplexes, which are in turn contained in endosomes, where each of these entities displays a behavior of its own. We have
created a mathematical model that reproduces both the time courses and the statistical variance observed in recent
experiments using single-cell tracking of GFP expression after transfection. By applying a few key simplifications and
assumptions, we have limited the number of free parameters to five, which we optimize to match five experimental
determinants by means of a simulated annealing algorithm. The models demonstrate the need for modeling of nested
species in order to reproduce the shape of the dose-response and expression-level curves.
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Introduction
Quantitative analysis of transfection is important for gene
therapy involving plasmid DNA and mRNA, as well as high-
throughput screening (HTS) and siRNA research [1–4]. For this
reason, it is important to know more about the kinetics and dose-
response relationship for delivery of genes and RNA-based nucleic
acid constructs and to understand the common principles that
underlie nucleic acid pharmacokinetics in any given cell type.
Many studies have collected quantitative data on the uptake and
pathway of gene carriers [5–10] and the physico-chemical
characterization of cationic lipoplexes and polyplexes has been
reviewed extensively [11–17]. In the last few years, first theoretical
considerations modeling the uptake and pharmacokinetics of
lipolexes using biochemical reaction kinetics have been undertaken
[18–20]. Some specialized models also address the spatial
distribution and active transport along microtubules [21]. The
stochastic nature of in the delivery process has been investigated
for nanoparticles [22] and for plasmid DNA [23]. The use of
movies for the analysis of single-cell tracking experiments has been
reviewed [24]. For modelling of biological systems in general,
there is an emerging set of tools in the context of systems biology,
including a new generation of computational methods, such as
process calculi and ‘‘executable biology’’ [25]. In fact, many
biological reactions require addition of stochastic modeling as well
as spatial aspects that go beyond reaction and diffusion [26]. For
example, endosomes contain lipoplexes and lipoplexes contain
mRNA molecules, and this can lead to a combinatorial explosion
in the number of variables and equations. The transfection process
requires the use of modeling techniques that have not been used
often, because substances can be contained in each other.
The problem of multi-level modeling has been treated in many
investigations and tools. Systems Biology Markup Language
(SBML) [27] and tools based on it, for example Cell Designer
[28] and Copasi [29], include the concept of compartments, which
contain species, but the compartments are only containers that
cannot support reactions of their own. First attempts to allow
modelling with compartments include the process calculus Pi
Calculus [30–35] and tools based on it, such as BioAmbients [36],
Beta-Binders [37–39] and the Stochastic Pi Machine SPiM [40].
In addition, the ‘‘rules-based’’ language BioNetGen Language
BNGL [41] and tools based on it, such as NFsim [42], contain
some very explicit methods for handling nested structures. One
example where these techniques were used is a model for the
uptake of nanoparticles is the work by Dobay et al. using SPiM
[43], which also demonstrates the need for multi-level modeling in
many situations involving nanoparticles.
Recently, we showed that quantitative analysis of transfection at
the single-cell level makes it possible to analyze the stochastic aspects
of transfection quantitatively [23,44]. The single cell exhibits time
courses that are characterized by a distinct delay time before the
onset of expression, a phase of GFP increase and finally a steady
state level. We showed that the distribution of steady-state levels was
related to the number of successfully delivered plasmids and well
described by an analytical model [23]. In the same spirit, we
analyzed the transfection of mRNA, which is more homogeneous
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and earlier compared to pDNA [45,46]. However, there is yet little
understanding regarding the kinetics of mRNA delivery. It is
generally accepted that mRNA lipoplexes are taken up via clathrin-
dependent endocytosis [47]. Existing models for RNA delivery
sometimes include a single ‘‘internalization’’ reaction, but that is not
sufficient for reproducing the data created by single-cell tracking
experiments. In particular, there is no kinetic model for the delivery
of mRNA that explicitly takes the compartments of the transfer
process into account.
Here we present a mathematical model, based on mass-action
kinetics, which describes the uptake of mRNA lipoplexes via
endocytosis and endosomal lysis. Our goal was to create a kinetic
model that reproduces experimental data, especially the distribu-
tion of time courses, and supports predictive modeling. While the
investigation of plasmid DNA [23] provides some background and
motivation, this model was based solely on the data published on
the experiment with mRNA [44]. We demonstrate that the uptake
kinetics is well described by a stochastic, mass action based model
that accounts for uptake of multiple lipoplexes. We solve the
problem of parameter estimation by choosing well-known rate
constants from literature and keeping five kinetic rates free, which
we optimize to meet the constraints of the experimental
transfection statistics and measured onset time distribution by
using a simulated annealing algorithm. As such, the model yields
uptake behavior that reproduces the experimental data and is
capable of predicting behavior beyond the experimental param-
eter regimes. The model also demonstrates the need for modeling
of nested species as well as modeling kinetic reactions in a
stochastic version in order to reproduce the shape of the dose-
response and expression-level curves, and the need to include the
maturation step in order to reproduce the variance of the onset-
time distribution. The benefit of predictive modeling and the
known limitations of the model are discussed.
Model Description
Streamlined Model
We model mRNA transfection by a sequence of mass-action
type chemical reactions (shown in Figure 1), which can be divided
into the delivery of lipoplexes and the GFP expression via the
mRNA released.
















Where Lex is the concentration of external lipoplexes, kA is the
rate at which lipoplexes attach to the cell surface, kW is the
washing rate, which is equal to zero at first and jumps to a high
value after the incubation time or normally one hour, P is the
concentration of clathrin-coated pits (i.e. number per cell), kE is the
rate of endocytosis, E is the concentration of endosomes (i.e.
number per cell), kL is the rate of lysis of endosomes, dE is the rate
of endosome degradation, Lin is the concentration of internal
lipoplexes, kU is the rate of lipoplex unpacking, dL is the rate of
degradation of lipoplexes, M is the concentration of mRNA, kU is
the rate of unpacking of lipoplexes, and dM is the rate of
degradation of mRNA. The degradation of endosomes is primarily
a model parameter to represent endosomes that are never
observed to lyse, and includes mRNA degradation in the
endosome.
The expression phase is described by the following ODEs, plus




Figure 1. Diagram of the streamlined transfection model. External (extracellular) lipoplexes attach to the surface of the cell, forming clathrin-
coated pits, which enter the cell via endocytosis, leading to the formation of endosomes, which either lyse or degrade. This puts the lipoplexes into
the cytosol, where they unpack, releasing the mRNA, which translates to unfolded GFP molecules, which then mature (folding and oxidation), to
produce active GFP. In addition to the endosomes, the lipoplexes, mRNA, immature and mature GFP are all degraded at set rates.
doi:10.1371/journal.pone.0107148.g001
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Where G is the concentration of immature (unfolded) GFP, kTL
is the rate of translation, kM is the rate of maturation (folding and
oxidation), dG is the rate of degradation of both immature and
mature GFP, and G* is the concentration of mature GFP. The
reaction rates are documented in Table 1.
This first model shows a very linear progression of single
lipoplexes attaching to and entering the cell, but we know from
experiment that endosomes can contain multiple lipoplexes, so we
need to address that and allow for endocytosis of multiple
lipoplexes per endosome. This means that we will have multiple
levels of containment.
Multi-Level Modeling
The solution to the complexity that arises from multiple levels of
structure is a key aspect of the model shown in Figure 2, so we will
describe it here in very general terms. For readers who are
interested in more detail, the File S1 contains the code of all
versions of the model.
The initial condition of external lipoplexes provides a first
example of this. In ordinary differential equations, we would use
the name of the lipoplexes (Lext or Lex) as a variable in the
equations. This variable refers to the concentration of lipoplexes,
or, equivalently, the number of particles in a given volume. In an
SBML-based [27] tool, this is also called a species. Now the
problem here is that the lipoplexes come in different sizes, based
on the number of mRNA molecules they contain. In the current
experimental situation we are modeling, the lipoplexes have a
mean diameter of 120 nm and a standard deviation of 10 nm.
This size was determined by fluorescence correlation spectroscopy
(data not shown). When we additionally take the packing density of
the lipoplexes into account, this size corresponds to a mean of 350
mRNA molecules per lipoplex and lipoplex sizes ranging from 270
to 445 mRNA molecules. See Supplementary data of Leonhardt
et al. [44] for a detailed description.
There are three solutions to this problem. First, we can use a
tool in which we can include a parameter for the size of the
lipoplex. In other words, we can write Lext(n), where n is the
number of mRNA molecules, and use that in the model. Second,
as an alternative, we can simply list all possible values of the size as
separate species, e.g. Lext270, Lext271 … Lext445. Finally, we
can apply a key simplification and assume that all lipoplexes
contain exactly 350 mRNA molecules.
Next, we need to consider the endosomes. Our experience with
both experimental data and modeling shows us that each
endosome can only contain a small number of lipoplexes, and
we are safe when we set this to an arbitrary maximum of 10. In
addition, each of those lipoplexes can contain anywhere from 270
to 445 mRNA molecules. In order to list all of these cases, we
would need more than 17510 different variables (or species),
something that is clearly impossible.
The key simplification in this paper, assuming that all lipoplexes
have the same size, along with listing all possible endosome sizes,
makes it possible to formulate the model in SBML and use Copasi
to run the simulations. We have also evaluated the use of other
tools and present those results here, for the benefit of experts in
those tools and modeling techniques in general. The second
implementation uses Pi-Calculus-based SPiM and preserves full
Table 1. Rates.
A parameters, fitted (optimized) and fixed







kA (attach) fitted .03 0.26 0.27 0.006–0.5 [20,21,59]
kE (endocytosis) fitted .8 0.73 0.81 0.16–0.5 [20,21,59]
kL (lysis) fitted .065 0.10 0.11 0.001–0.96 [20,21,59]
kM (maturation) fitted or
fixed
5.5 9.23 5.5 0.5–9.23 [48,60–63]
dE (endosome degradation) fitted 0.65 0.60 0.67 n.a.
kU (unpack) fixed 1e+06 1e+06 1e+06 n.a.
dL (lipoplex degradation) fixed 1e–06 1e–06 1e–06 n.a.
kTL (translation) fixed 170 170 170 170 [44]
dM (mRNA degradation) fixed 0.062 0.062 0.062 0.062 [44]
dG (GFP degradation) fixed 0.056 0.056 0.056 0.056 [44]
B experiment vs. simulation
TE (transfection efficiency) target 40 44 36 38
LC (lipoplexes on cell) target 6 6.43 6.02 6.03
maxGFP target 7.09e+5 4.32e+5 4.91e+5 5.34e+5
t0-mean target 3.14 3.36 3.49 3.23
t0-width target 1.54 1.72 2.05 1.65
A) The table shows the rate constants used by the simulation. During optimization, kA, kE, kL, and dE were varied, and kM was varied in one case. Column ‘‘streamlined
with slow maturation’’ is the streamlined model with kM = 5.5 fixed. Column ‘‘multiple-lipoplex with fast maturation’’ is the multiple-lipoplex model with kM = 9.23 fixed
to the value from literature. Column ‘‘multiple-lipoplex with slow maturation’’ is the multiple-lipoplex model with kM varied (optimized). The literature values are
described in more detail in the File S1. B) The last 5 rows are the experimental data used as a goal in optimization.
doi:10.1371/journal.pone.0107148.t001
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complexity, except that we used a smaller width for the lipoplex
size distribution in order to keep the code smaller. The variable
sizes of the lipoplexes are kept throughout their lifetime, and the
variable sizes of pits and endosomes are represented by listing all
possible values, due to limitations in formulating reactions of
parameters in SPiM (as opposed to processes). The third version
uses the rule-based language BioNetGen Language (BNGL) in the
tool NFsim, and exposes a limitation that prevents us from using a
parameter (such as the number of mRNA molecules in a lipoplex)
in a reaction without setting it to an explicit value.
Multiple-Lipoplex Model
The multiple-lipoplex model (Figure 2) follows the lines of the
streamlined model (heavy arrows), but also includes the formation
of clathrin-coated pits that include multiple lipoplexes.
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and equation (5) from above, where Pi is the concentration of
clathrin-coated pits of size i, i.e. containing i lipoplexes, Ei is the
concentration of endosomes of size i, and the new rate of
attachment is kAX calculated by dividing kA by the number of pits
plus one, in order to assure a constant rate of attachment even
when the number of pits increases. All other symbols are the same
as in the streamlined model.
The expression phase is described by the same ODEs as in the
streamlined model, (5), (6), and (7).
This model, in contrast to the streamlined model, includes
different-sized lipoplexes, with their sizes preserved through all
reactions up to unpacking. This seemingly easy extension allowing
variable lipoplex sizes and variable endosome sizes leads to a
severe combinatorial explosion of species and reactions. For the
analysis included in this paper, we have avoided a large part of this
issue by assuming that all lipoplexes have the same size. This is a
very significant simplification, but nevertheless allows fairly good
simulation results, and makes it possible to run simulations both
deterministically and stochastically, and also to run parameter
estimation.
We created 3 implementations of the model. The first is written
in SBML, was run in Copasi, and assumes a very significant
simplification (all liposomes have the same size); it was used for the
analysis in this paper. The second is written in Pi Calculus and was
run in the Stochastic Pi Machine (SPiM), and includes a limited
example of variable-sized lipoplexes. The third is written in BNGL
and was tested in NFSim.
Parameter Optimization
In order to compare the model to the experimental data, the
best values need to be found for the five parameters that have been
left free, such as the rate of endocytosis. This requires adjusting the
model to best fit the five experimental determinants, such as the
dose-response relationship. However, since the experimental data
Figure 2. Diagram of the multiple-lipoplex transfection model. This includes the same processes as in the streamlined model, except that
here the clathrin-coated pits and the endosomes can contain multiple lipoplexes.
doi:10.1371/journal.pone.0107148.g002
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is based on single-cell tracking, it includes the variance of the
distributions of multiple time courses. As a result, each attempt to
find a better value for the parameters requires two steps: First, it is
necessary to run the simulation many times (typically 1,000–5,000)
and second, to compare the distributions with the experimental
data. In all cases where we compare simulation data to
experimental data, we use the same analytical model for the
expression phase and the same fitting procedures for both data
sets, in order to make a good comparison between simulation and
experiment, as reported in [44].
Since we are optimizing a stochastic model, we have chosen to
use the simulated annealing algorithm. This algorithm chooses a
new set of values for the parameters, based on random numbers,
then runs the two steps of simulation and analysis described above,
and compares the results with the experimental data. The
comparison involves the current value of a ‘‘temperature’’ variable
and the Boltzmann function in order to allow the algorithm to
move away from local optima that may not be globally optimal.
The first two parameters in the model are the initial
concentration of external lipoplexes and the incubation time (time
until the cells are washed). These parameters are not part of the
optimization process, since they are determined by experiment,
but they do appear in the plots we have created of the dose-
response relationship and incubation dependency, which we also
compare with experimental data. In addition, we have varied these
parameters as part of predictive modeling.
The parameters in the optimization process are the rates of
attachment, endocytosis, and lysis, along with the rate of
endosome degradation, plus the rate of GFP maturation. We
optimize these five parameters to match five data points from the
experimental data: The number of lipoplexes that attach to the cell
surface (4–8), the dose-response curve (transfection efficiency vs.
dose), the mean and variance of the onset time of GFP expression
are as reported in [44], and the mean maximum GFP expression
level. This gives us a good estimate of these five parameters.
The remaining parameters that need optimization are thus the
rates of lysis and unpacking. Currently, we don’t have a way to
distinguish between delays caused by lysis vs. unpacking, so we set
unpacking to be immediate. In addition, we assume no negligible
degradation of lipoplexes, so we set that rate to a small number.
The values of all parameters, both fixed and fitted, are
documented in Table 1. Due to the significant simplifications
involved in the model, and the inherent ‘‘sloppiness’’ of models
with this many parameters, we do not consider the parameters to
be accurate measurements of the real values. The value of the
model is demonstrated more by its overall performance and
matching with the experimental data.
Model Implementations
The formulation of the SBML implementation of the model is
based on reactions, and is a very straightforward step from the
reactions documented here. The only difference is the fact that
some species are listed, such as End1…End10, instead of the
subscripted notation Endi i = 1…10 used in the documentation.
The Pi Calculus implementation is discussed in the File S1. This
implementation of the model, which was run in SPiM, deals with
the variable lipoplex size by including the size as a parameter in
the process. It is an implementation of the model in Pi Calculus
where the number of lipoplex sizes (the width of the lipoplex size
distribution) is restricted to 11, even though 175 is required. This
model was run and produced the same data as the Copasi model
with only 1 lipoplex size.
The BNGL implementation is discussed in the File S1. This is a
prototype of an implementation of the model written in BNGL
and run in NFSim. This implementation does not cover enough of
the model to produce useful data.
Results and Discussion
Time Courses
Since we are dealing with low copy numbers in the first parts of
the transfection process, we need to account for the stochastic
nature of them, and see how that compares with a more traditional
solution to the equations. Figure 3 shows time courses created by
deterministic simulation, i.e. by numerical solution of the
differential equations in the green dotted line, and a typical
example of time courses created by stochastic simulation, i.e. using
Monte Carlo simulation via the Gillespie algorithm in the red full
line. The important message in this figure is the very significant
difference between deterministic and stochastic simulations. Due
to the low copy numbers involved (except for GFP), the
deterministic plots are not good representations of the biological
reality, and they do not necessarily represent the average behavior
of the stochastic simulations. However, they are sometimes useful
for running early steps in the parameter estimation task. Figure 3A
shows the number of lipoplexes attached to the cell surface, which
grows rapidly until the cells are washed after 1 hour of incubation,
and then decays exponentially as they enter the cell. Figure 3B
shows the number of lipoplexes in endosomes, which demonstrates
how they enter and leave the endosomes. Figure 3C shows the
number of mRNA molecules, where our example of a stochastic
simulation shows that 1 lipoplex (containing 350 mRNA
molecules) has entered the cell; this can vary from 0 to about 5.
Figure 3D shows the number of GFP molecules, which first
increases after mRNA molecules appear and begin to translate,
then decreases due to degradation of both mRNA and GFP.
Now that we have set our focus on stochastic simulation time
courses, we would like to see how they compare with the
experimental data. Figure 4 is another visualization of the GFP
time course presented earlier. Figure 4A shows the simulation
data. The clustering of the absolute height of the curves results
from the fact that mRNA molecules are delivered in ‘‘packets’’, i.e.
lipoplexes of size 350. We consider this to be a result of the
simplification where we assumed all lipoplexes to contain exactly
350 mRNA molecules, even though the range (within one
standard deviation) goes from 270 to 445. This clustering behavior
was not observed in the experimental data. The horizontal axis
clearly shows the variation in the onset time, and the vertical axis
shows the variation in expression level (maximum GFP concen-
tration). These two distributions will be examined in more detail
below. Figure 4B shows the experimental data. In the plots, it
appears as though the absolute level of GFP expression differs by a
factor of 4. However, the value used for parameter optimization
was the mean of the maximum GFP expression level, and that is
7.16105 in the experiment and 5.46105 in the simulation. The
other values used for optimization varied much less (see Table 1).
The time for reaching a peak value in Figure 4B is not easy to see,
so we calculated the mean and variance of both distributions, and
found that both peak at about 20 hours with a standard deviation
of about 5.5 hours.
Simulation vs. Experiment
In order to compare simulation with experiment, probability
distributions of some of the key parameters are shown in Figures 5
and 6. In all cases, the experimental data refers to the data
published in [44]. Figure 5 shows the onset time of GFP
expression, which is defined as the first time where GFP can be
detected, and we have measured it by fitting the analytic solution
mRNA Delivery Model
PLOS ONE | www.plosone.org 5 September 2014 | Volume 9 | Issue 9 | e107148
of the expression kinetics to the experimental data and the
simulations using the same technique as in the original paper [44].
This makes it unnecessary to use an arbitrary threshold for GFP or
to use the simple slope of the curve to determine onset time. The
maturation reaction was not included in the original analysis in
[44], which means that the maturation delay was included in the
onset time there. The green dashed line kM = 9.23 (fitted
parameters 3.5 mean and 2.1 width), from literature [48], and
solid red line kM = 5.5 (fitted parameters 3.2 mean and 1.6 width),
as determined by our parameter optimization. The dotted blue
lines show the onset times of the experimental data (fitted with 3.1
mean and 1.5 width). The reason for the difference lies in the fact
that all reactions have a small copy number, and thus a large
stochastic variation, except for the maturation reaction. We know
that, for Poisson processes, the mean is proportional to the number
of reactants, and the width is proportional to the square root of the
number of reactants, and this number is on the order of 1–100 for
endocytosis, 1–100 for lysis, 1–100 for unpacking, 300–2000 for
Figure 3. Simulation Time Courses. Green dotted (red full) line: deterministic (stochastic) simulation. A) Number of lipoplexes attached to the cell
surface. B) Number of lipoplexes contained in endosomes. C) Number of mRNA molecules in the cell. D) Number of GFP molecules in the cell.
doi:10.1371/journal.pone.0107148.g003
Figure 4. GFP expression: simulation vs. experiment. A) Computer simulation. B) Experimental time courses.
doi:10.1371/journal.pone.0107148.g004
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translation, and 200,000–5,000,000 for maturation. In order to
match the experimental results, our optimization routine found a
maturation rate of 5.5 h21 or 11 min delay. In contrast, the rate of
kM = 9.23 (6.5 min) from literature produces a distribution that is
too wide. Maturation delays of 20 or 30 minutes also match the
experimental data well. This is within the range of published
EGFP maturation rates, which vary widely and go as high as a few
hours due to the time required for oxidation (more details in File
S1). This figure was created in the multiple-lipoplex model, but the
streamlined model shows exactly the same behavior, i.e. it is
capable of reproducing the experimentally-measured onset time
distribution, but also needs the maturation reaction to do so.
Now that we have seen the comparison of simulation and
experiment for the onset time of GFP expression, we need to look
at how much GFP is created in the cells. Figure 6A shows the
distribution of the maximum number of GFP molecules, as
determined by fitting the analytical solution of gene expression
(translation and degradation) to the data of simulation and
experiment. This is the value that we use to determine the level of
expression, and, along with the degradation rates, it uniquely
determines the time course of GFP expression. The dashed green
lines are from a simulation of the streamlined model (fitted with
4.3*105 mean and 0.47 width). The solid red lines are from a
simulation of the multiple-lipoplex model (fitted with 5.3*105
mean and 0.69 width). The dotted blue lines show the
experimental data (fitted with 7.1*105 mean and 1.1 width). We
can see that the simulation of the streamlined model misses the
experimental results significantly, which we attribute to the fact
that the streamlined model never transports more than one
lipoplex per endosome. In contrast to the streamlined model, the
multiple-lipoplex model allows a better match to the expression
level data. The use of lognormal curves to fit the simulation and
experimental data in Figure 6A is more than a convenient guide
for the eye; they provide a good representation of the data, since
the GFP expression is the result of multiple random processes.
Along with the maximum amount of GFP expressed, we are
also interested in seeing how the amount of GFP compares with
the dosage of lipoplexes, i.e. the concentration presented to the
cells. Figure 6B shows the dose-response relationship, defined as
transfection efficiency, i.e. percentage of cells that successfully
express GFP vs. concentration of mRNA. The green open
triangles are from the simulation of the streamlined model, and
the dashed green line is a single-Poissonian fit (fitted parameter
1.1). The open red circles are from the simulation of the multiple-
lipoplex model and the solid red line is a double-Poissonian fit
(fitted parameters 1.9 and 0.6). The solid blue squares are from the
experimental data and the dotted blue line is a double-Poissonian
fit (fitted parameters 1.1 and 0.9). In Figure 6B, we can see that
the simulation of the streamlined model is much too straight and
significantly misses the shape of the experimental results, which we
attribute to the fact that the streamlined model never transports
more than one lipoplex per endosome. In fact, the good fit of a
single Poissonian to the streamlined model is a clear indication
that one of the Poissonian processes, representing the number of
lipoplexes per endosome, is missing in this model. This process is
referred to as Leff in the original paper, and the process that is
included in the streamlined model is referred to as Neff [44], File
S1. The dose-response relationship for the multiple-lipoplex model
shows a reasonable fit to a double Poissonian and to the
experimental data, and is a big improvement over the streamlined
model.
Figure 5. Onset time of GFP expression (Simulation vs.
Experiment based on time courses shown in Figure 4). The
curves are Gaussian curves based on mean and variance of the full
distribution data (shown as a histogram). The dashed green lines show
the onset times for simulation with a maturation rate (kM) of 9.23 taken
from literature. The solid red lines show the onset times for simulation
with a maturation rate (kM) of 5.5. The dotted blue lines show the onset
times of the experimental data.
doi:10.1371/journal.pone.0107148.g005
Figure 6. GFP expression (Simulation vs. Experiment based on
time courses shown in Figure 4). A) Expression Level. Maximum
number of GFP molecules with histograms of the distributions and
lognormal fits of the histograms as curves. The dashed green lines are
from a simulation of the streamlined model. The solid red lines are from
a simulation of the multiple-lipoplex model. The dotted blue lines show
the experimental data. B) Dose-Response Relationship. Transfection
efficiency (TE) is the percentage of cells that exhibited a successful
transfection, based on GFP expression. The curve was determined by
varying the dosage (mg/ml) in the experiment, and the initial
concentration of lipoplexes in the simulation (Lex). The green open
triangles are from the simulation of the streamlined model, and the
dashed green line is a single-Poissonian fit. The open red circles are
from the simulation of the multiple-lipoplex model and the solid red
line is a double-Poissonian fit. The solid blue squares are from the
experimental data and the dotted blue line is a double-Poissonian fit.
doi:10.1371/journal.pone.0107148.g006
mRNA Delivery Model
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We can summarize these differences by observing that the
streamlined model is capable of reproducing the delay and
variance of the onset time of GFP expression, but the multiple-
lipoplex model is required to reproduce the dispersion of the data.
In other words, multi-level modeling is necessary for reproducing
the dispersion of the data, because it is the only model that
includes the second Poisson process discussed in the experimental
paper.
Predictive Modeling
The power of mathematical modeling is its capability to predict
the behavior of systems before running experiments. It is
instructive to test the outcome of our simulation for various
scenarios of practical relevance in our lab work. In the following,
the red circles show the transfection efficiency (percentage of cells
transfected) and the green triangles show the maximum GFP
expression level.
For determining the dosage presented to the cells, the
incubation time, i.e. the time until the cells are washed, plays an
important role. Figure 7A shows the transfection efficiency (TE)
and the maximal number of eGFP expressed (GFP) as a function
of incubation time. The model predicts a strictly linear relation of
incubation time and transfection efficiency. This outcome is due to
the fact that the model assumes a constant concentration of
lipoplexes in bulk and hence a constant diffusion-limited flux. Yet
we expect this dependence to be only observable in a very limited
time window avoiding saturation of the uptake capacity of the cells
as well as the depletion of the lipoplex pool. Most importantly,
however, the model does not account for increasing toxic side
effects that come with increasing dose.
In this model, the endosome degradation rate is a catch-all for
any kind of degradation that occurs before endosomal lysis,
especially mRNA degradation, so a small endosome degradation
rate should show the benefit of improved mRNA stability.
Figure 7B shows the transfection efficiency (TE) and the maximal
number of eGFP expressed (GFP) as a function of endosome
degradation rate. The solid red and green lines are exponential
fits. The exponential increase of transfection efficiency with
decreasing degradation rate clearly shows the (expected) benefit
of increasing the stability of mRNA. It is interesting to note that
the averaged eGFP per expressing cell exhibits a steeper
dependence than the fraction of transfected cells (transfection
efficiency). When we extrapolate the exponential fits to the point
where the endosome degradation rate is zero, we can see that the
model predicts approximately 100% transfection efficiency and
1,000,000 maximum GFP for the case of perfectly stable mRNA.
Extrapolation to an infinite degradation rate (absolutely unstable
mRNA) predicts approximately 0% transfection efficiency as
expected. However, this is only approximately 0%, and maximum
GFP expression is only calculated for successfully transfected cells,
so when we extrapolate to an infinite degradation rate, we see
500,000 GFP molecules per cell, but this is an artifact of the
analysis. We should also recall that our model was optimized to an
average of 6 lipoplexes adhering to each cell.
In order for the lipoplexes to reach the cytosol and be expressed,
they first need to escape from the endosomes, which we have
modeled in the endosomal lysis rate. Figure 7C shows the
transfection efficiency (TE) and the maximal number of eGFP
expressed (GFP) as a function of the lysis rate. The solid red line is
an exponential fit while and the solid green line is a linear fit. The
increase of transfection efficiency with increasing lysis rate
demonstrates the (expected) improvement of transfection with
increasing lysis, or endosomal escape [4,9,49–52]. We expect a
similar effect when changing the attach rate via the use of
magnetofection [8].
The size of the lipoplexes may have an important influence on
their uptake. Figure 7D shows the transfection efficiency (TE) and
the maximal number of eGFP expressed (GFP) as a function of the
lipoplex size. We can see that the model predicts a higher
percentage of cells transfected when the lipoplexes are smaller (but
total mRNA concentration kept the same), and a higher total
amount of GFP when the lipoplexes are larger. This opposing
Figure 7. Predictive Modeling. All plots show a parameter vs. transfection efficiency (TE, red circles) and protein expression (GFP, green triangles).
The lines are linear or exponential fits. A) Incubation time. B) Endosome degradation rate. C) Lysis rate. D) Lipoplex size.
doi:10.1371/journal.pone.0107148.g007
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effect occurs because we assume a constant uptake rate
independent of size and smaller lipoplexes mean a larger number
of them, which increases the probability of successful transfection,
while larger lipoplexes are capable of transporting more material.
A size-independent uptake rate, however, is taken with a very big
caveat. In fact, the dependence of uptake on size has been shown
in experiment for gold nanoparticles [53–56]. Yet, there is some
value to the finding that in case of variation of experiments focused
on an optimal lipoplex size, in which case the size dependence
might be weak, transfection efficiency and GFP expression react in
the opposite direction.
Conclusions and Outlook
We have presented a kinetic model for mRNA delivery via
transfection of lipoplexes. The model consists of a chain of transfer
events including lipoplex attachment, endocytosis, endosomal lysis,
unpacking, translation and maturation. It was shown that
parameter estimation allows direct comparison to the outcome
of a single-cell transfection analysis. The model provides a kinetic
model that reproduces both the delay and dispersion of the onset
time and also the dose-response relationship. The delay can be
reproduced using the streamlined model, but the multiple-lipoplex
model, which is based on multi-level modeling, is necessary in
order to reproduce the dispersion of the data. The key findings are
that in order to achieve the observed level of GFP expression, as
expressed in the maxGFP distribution, we need to use the
multiple-lipoplex model. A multiple-lipoplex model achieves the
correct width (stochastic variance) of the probability distribution
for the onset time of GFP expression if the maturation reaction is
included. A hallmark of the multiple-lipoplex model is its
combinatorial manifold, which exceeds the capacity of ordinary
modeling platforms. We showed that a reduction of the
combinatorial space to a limited variance was able to approximate
the shape of the dose-response relationship.
Extensions of the model that might be necessary as more refined
data become available are more explicit rate equations that
include cooperative behavior (Hill kinetics) or e.g. enzyme limited
reactions (Michaelis Menten type kinetics). Furthermore, degra-
dation processes could be broken down into specifically known
pathways. Yet the most important uncertainty concerns the uptake
process itself. The fact that we used a single, uniform rate of
attachment of lipoplexes to clathrin-coated pits and that the rate of
endocytosis in our model does not depend on the size of the pit is
first of all due to missing quantitative data. We have assumed that
endosomes first undergo lysis, then the lipoplexes are unpacked,
and then the mRNA can begin translation and degradation.
However, unpacking might occur within the endosome before lysis
and, as mentioned earlier, mRNA degradation might begin in the
endosome before lysis. Furthermore, we don’t currently have a
way to distinguish between a delay caused by lysis and delay
caused by unpacking, so we have simplified the model to treat
unpacking as an immediate reaction.
A key aspect of this investigation is multi-level modeling, which
leads to a combinatorial explosion of variables and reactions, but
this could be solved more elegantly by a computational system that
copes with it directly. However, this does not make the
combinatorial explosion disappear; the burden is simply trans-
ferred from the user to the tool in the form of dynamic creation of
species. The basis for this already exists in SBML, Copasi, SPiM,
BioNetGen, NFsim, and ML-Rules, which introduces the concept
of nested species [57,58], meaning that one species, such as
mRNA molecules, can exist and exhibit behavior within another
species, such as a lipoplex or endosome. This would make it
possible to formulate the model in a more elegant way, which
would be easier to understand. As a second benefit, it would make
it possible to remove a significant limitation of today’s model,
which assumes that all lipoplexes have the same size and leads to a
clustering of GFP expression levels visible in Figure 4, and it would
be possible to model explicit unpacking of lipoplexes and
degradation of mRNA within endosomes, instead of resorting to
an endosome degradation reaction, as shown in the fully nested
model (Figure 8). Finally, it would also make it possible to use
species as building blocks to create new ones; for example,
chemical reaction networks could be used to build organelles,
which could be used to build cells, etc. This type of model is often
required for nanoparticle transport in general, and should provide
a basis for more predictive modeling in that area.
Beside all well-founded shortcomings of the current model
limitations, there is substantial value added by comparison of
modeling and experimental data. The fact that data are
reproduced by a set of parameters that is optimized by the same
number of experimental determinants justifies our assertion that
the model has significant predictive power. We have done
predictive modeling by analyzing the effect of varying parameters,
and the results either agree with existing experimental data (e.g.
dose-response), confirm known aspects (e.g. importance of
endosomal escape), or predict new effects, such as the effect that
decreasing the size of the lipoplexes has on transfection efficiency
and GFP expression.
With appropriate modifications, this model should be useful for
new experimental work. The key parameters include the rates of
attachment, endocytosis, lysis, unpacking, and the size-dependen-
cy of those rates; as new data on these parameters becomes
available, this should lead to a significant improvement in the
quality of the model.
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